Clinical trial
Depression and Health Outcomes in Refractory Epilepsy
NCT00026637 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00026637 |
|---|---|
| Title | Depression and Health Outcomes in Refractory Epilepsy |
| Official title | Depression and Health Outcomes in Refractory Epilepsy |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Epilepsy |
| Intervention type | Behavioral, Drug |
| Interventions | sertraline, cognitive behavior therapy |
| Enrollment | 140 |
| Start date | Aug 1, 2001 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Nov 15, 2001 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: